Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMIFENTANIL for Foetal exposure during pregnancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 35 adverse event reports in the FDA FAERS database where REMIFENTANIL was used for Foetal exposure during pregnancy.

Most Reported Side Effects for REMIFENTANIL

Side Effect Reports % Deaths Hosp.
Anaphylactic shock 351 12.8% 17 114
Hypotension 195 7.1% 13 71
Anaphylactic reaction 178 6.5% 16 59
Cardiac arrest 145 5.3% 35 37
Bradycardia 132 4.8% 11 56
Foetal exposure during pregnancy 132 4.8% 2 37
Drug ineffective 112 4.1% 22 41
Off label use 109 4.0% 25 60
Anaesthetic complication neurological 96 3.5% 0 3
Premature baby 91 3.3% 2 16
Drug interaction 78 2.9% 0 22
Tachycardia 76 2.8% 4 27
Toxic epidermal necrolysis 66 2.4% 47 61
Cardio-respiratory arrest 65 2.4% 23 15
Exposure during pregnancy 57 2.1% 0 8

Other Indications for REMIFENTANIL

General anaesthesia (516) Anaesthesia (483) Maintenance of anaesthesia (395) Induction of anaesthesia (331) Product used for unknown indication (300) Sedation (176) Analgesic therapy (93) Anaesthesia procedure (63) Sedative therapy (36) Induction and maintenance of anaesthesia (31)

Other Drugs Used for Foetal exposure during pregnancy

HYDROXYPROGESTERONE CAPROATE (4,042) ONDANSETRON (1,061) ASPIRIN (485) BETAMETHASONE (475) PREDNISONE (429) ACETAMINOPHEN (428) OXYCODONE (414) LEVETIRACETAM (401) TACROLIMUS (382) LAMOTRIGINE (343)

Related Pages

REMIFENTANIL Full Profile All Foetal exposure during pregnancy Drugs REMIFENTANIL Demographics REMIFENTANIL Timeline